Kodiak Sciences Inc (KOD)
6.21
+0.31
(+5.25%)
USD |
NASDAQ |
Nov 22, 13:33
Kodiak Sciences Total Liabilities (Quarterly): 187.30M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 187.30M |
| June 30, 2024 | 187.07M |
| March 31, 2024 | 193.57M |
| December 31, 2023 | 213.59M |
| September 30, 2023 | 245.24M |
| June 30, 2023 | 251.18M |
| March 31, 2023 | 247.75M |
| December 31, 2022 | 230.46M |
| September 30, 2022 | 244.46M |
| June 30, 2022 | 250.97M |
| March 31, 2022 | 252.90M |
| December 31, 2021 | 240.90M |
| September 30, 2021 | 231.89M |
| June 30, 2021 | 218.17M |
| Date | Value |
|---|---|
| March 31, 2021 | 211.06M |
| December 31, 2020 | 206.60M |
| September 30, 2020 | 198.96M |
| June 30, 2020 | 120.17M |
| March 31, 2020 | 115.36M |
| December 31, 2019 | 13.51M |
| September 30, 2019 | 9.225M |
| June 30, 2019 | 8.256M |
| March 31, 2019 | 6.982M |
| December 31, 2018 | 5.356M |
| September 30, 2018 | 110.94M |
| June 30, 2018 | 5.046M |
| December 31, 2017 | 71.98M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
13.51M
Minimum
Dec 2019
252.90M
Maximum
Mar 2022
203.05M
Average
215.88M
Median
Total Liabilities (Quarterly) Benchmarks
| Pfizer Inc | 126.92B |
| Regeneron Pharmaceuticals Inc | 8.116B |
| Acumen Pharmaceuticals Inc | 49.77M |
| NovaBay Pharmaceuticals Inc | 2.805M |
| Palatin Technologies Inc | 11.10M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 372.67M |
| Shareholders Equity (Quarterly) | 185.37M |